Cite
The novel metabotropic glutamate receptor 2 positive allosteric modulator, AZD8529, decreases nicotine self-administration and relapse in squirrel monkeys
MLA
Yavin Shaham, et al. The Novel Metabotropic Glutamate Receptor 2 Positive Allosteric Modulator, AZD8529, Decreases Nicotine Self-Administration and Relapse in Squirrel Monkeys. Feb. 2015. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....cd472c5ea0574a282f71a775f49f2b3e&authtype=sso&custid=ns315887.
APA
Yavin Shaham, Alan J. Cross, Maria E Secci, Zuzana Justinova, Amy Medd, Charles W. Schindler, Steven R. Goldberg, Leigh V. Panlilio, Godfrey H. Redhi, & Ladislav Mrzljak. (2015). The novel metabotropic glutamate receptor 2 positive allosteric modulator, AZD8529, decreases nicotine self-administration and relapse in squirrel monkeys.
Chicago
Yavin Shaham, Alan J. Cross, Maria E Secci, Zuzana Justinova, Amy Medd, Charles W. Schindler, Steven R. Goldberg, Leigh V. Panlilio, Godfrey H. Redhi, and Ladislav Mrzljak. 2015. “The Novel Metabotropic Glutamate Receptor 2 Positive Allosteric Modulator, AZD8529, Decreases Nicotine Self-Administration and Relapse in Squirrel Monkeys,” February. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....cd472c5ea0574a282f71a775f49f2b3e&authtype=sso&custid=ns315887.